Professor of Medicine and Biochemistry, Stanford University
Oncology
Dr. Gilbert Chu, MD
|
|
Give Review
Doctor Gilbert Chu, MD is an expert in the field of Oncology. He studied medicine at Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 4 awards "Regional Top Doctor", "Clinical Scientist Award for Translational Research", "Scholar" and "CMS Meaningful Use Stage 1 Certification". Gilbert is also published. He has 25 publications published. The lastest publication: "Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.'
Publications
- Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.
- Cooperative assembly of a protein-DNA filament for nonhomologous end joining.
- Electrophoretic mobility shift assays for protein-DNA complexes involved in DNA repair.
- An information theoretic, microfluidic-based single cell Analysis permits identification of subpopulations among putatively homogeneous stem cells.
- Local false discovery rate facilitates comparison of different microarray experiments.
- Here comes the sun: recognition of UV-damaged DNA.
- Crystal structure of human XLF: a twist in nonhomologous DNA end-joining.
- Cernunnos/XLF promotes the ligation of mismatched and noncohesive DNA ends.
- Processing of DNA for nonhomologous end-joining is controlled by kinase activity and XRCC4/ligase IV.
- Assays for nonhomologous end joining in exTracts.
- Electrophoretic mobility shift assays to study protein binding to damaged DNA.
- UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex.
- Immune signatures in follicular Lymphoma.
- Processing of DNA for nonhomologous end-joining by cell-free exTract.
- Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells.
- Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage.
- Contributions of ATM mutations to familial breast and ovarian Cancer.
- Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein.
- Interaction between UV-damaged DNA binding activity proteins and the c-Abl tyrosine kinase.
- Global genomic repair and p53 in a dance after DNA damage.
- Mutation of the ATM gene is not involved in the pathogenesis of either follicle center Lymphoma or its transformation to higher-grade Lymphoma.
- Synapsis of DNA ends by DNA-dependent protein kinase.
- Diagnosis of multiple Cancer types by shrunken centroids of gene expression.
- p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice.
Schools
Harvard Medical School
Massachusetts General Hospital
Stanford University Med Center
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- Clinical Scientist Award for Translational Research
- Scholar
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
Stanford Health Care
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417083684 |
| Last Name Of The Provider | CHU |
| First Name Of The Provider | GILBERT |
| View All |
Similar Doctors
|
|
Dr. Joshua Brody, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel W. Neal, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ina P. Rhee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen N. Ganjoo, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Gregory K. Behbehani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sandhya Srinivas, MB
This Doctor is OpenDoctor Recommended.
|